← Leaderboards
Bradley Vince
$3,647,922
Attributed
$3,647,922
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.5M · FY2014–17$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
Funding mix
By agency
NIH$3,647,922 · 1
By mechanism
N01$3,647,922 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cannabis”
- Gavin Bart · Rockefeller University$20,453,700
- Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai$18,850,706
- Deepak Cyril D'souza · Va Connecticut Healthcare System$17,740,756
- Richard A Miech · Johns Hopkins University$17,538,220
- Linda Chang · La Biomed Res Inst/ Harbor Ucla Med Ctr$17,170,784
- Herbert David Kleber · New York State Psychiatric Institute$16,737,999
Research focus
CannabisCocaineContractorDrug KineticsMethamphetamineOpiatesPharmaceutical PreparationsPharmacodynamicsPharmacologyStemTobacco
Grant awards (4)
IGF::OT::IGF Pharmacokinetic and Pharmacodynamic Studies for Medications Development; POP 9/14/12 - 9/13/17, FY12 N01DA-12-8905$413,284
N01 · FY2017 · DA · contact PI
IGF::OT::IGF Pharmacokinetic and Pharmacodynamic Studies for Medications Development; POP 9/14/12 - 9/13/17, FY12 N01DA-12-8905$323,991
N01 · FY2016 · DA · contact PI
IGF::OT::IGF Pharmacokinetic and Pharmacodynamic Studies for Medications Development; POP 9/14/12 - 9/13/17, FY12 N01DA-12-8905$369,793
N01 · FY2015 · DA · contact PI
IGF::OT::IGF Pharmacokinetic and Pharmacodynamic Studies for Medications Development; POP 9/14/12 - 9/13/17, FY12 N01DA-12-8905$2,540,854
N01 · FY2014 · DA · contact PI